![ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells | Oncogene ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells | Oncogene](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.onc.1206066/MediaObjects/41388_2003_Article_BF1206066_Fig6_HTML.jpg)
ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells | Oncogene
![Frontiers | Early Pathogen Recognition and Antioxidant System Activation Contributes to Actinidia arguta Tolerance Against Pseudomonas syringae Pathovars actinidiae and actinidifoliorum Frontiers | Early Pathogen Recognition and Antioxidant System Activation Contributes to Actinidia arguta Tolerance Against Pseudomonas syringae Pathovars actinidiae and actinidifoliorum](https://www.frontiersin.org/files/Articles/521401/fpls-11-01022-HTML/image_m/fpls-11-01022-g001.jpg)
Frontiers | Early Pathogen Recognition and Antioxidant System Activation Contributes to Actinidia arguta Tolerance Against Pseudomonas syringae Pathovars actinidiae and actinidifoliorum
![Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen | Journal of Urology Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen | Journal of Urology](https://www.auajournals.org/cms/asset/e8aac3c7-8046-43a3-8859-06c809e09b13/abs-fig.jpg)
Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen | Journal of Urology
![Time to an undetectable prostate‐specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer‐specific mortality - D'Amico - 2007 - Cancer - Wiley Online Library Time to an undetectable prostate‐specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer‐specific mortality - D'Amico - 2007 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/cbb2eaf1-7e31-4fbd-b032-49ca8a2f75cf/mfig002.jpg)
Time to an undetectable prostate‐specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer‐specific mortality - D'Amico - 2007 - Cancer - Wiley Online Library
![Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice](https://bjgp.org/content/bjgp/71/706/e364/F1.large.jpg)
Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice
Correction: A quantitative evaluation of a qualitative risk assessment framework: Examining the assumptions and predictions of the Productivity Susceptibility Analysis (PSA) | PLOS ONE
![Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy](https://www.frontiersin.org/files/Articles/656444/fonc-11-656444-HTML/image_m/fonc-11-656444-t002.jpg)
Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
![ASCO-GU 2023: Baseline characteristics associated with PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19). ASCO-GU 2023: Baseline characteristics associated with PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19).](https://larvolclin.s3.us-west-2.amazonaws.com/resize_167666501884636583063efe0ba9ca5b.jpg)
ASCO-GU 2023: Baseline characteristics associated with PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19).
![Effect of adsorption temperature on PSA performance. (a) CO purity, (b)... | Download Scientific Diagram Effect of adsorption temperature on PSA performance. (a) CO purity, (b)... | Download Scientific Diagram](https://www.researchgate.net/publication/353942408/figure/fig7/AS:1082760382947338@1635161600401/Effect-of-adsorption-temperature-on-PSA-performance-a-CO-purity-b-CO-recovery-and.png)
Effect of adsorption temperature on PSA performance. (a) CO purity, (b)... | Download Scientific Diagram
![PDF] Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer? | Semantic Scholar PDF] Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/691ac9ac271e57476df58d793f1e78a2761ce3af/2-Table1-1.png)
PDF] Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer? | Semantic Scholar
![Comparative study stratified by the PSA cut off level of 1.4 (ng/mL) in... | Download Scientific Diagram Comparative study stratified by the PSA cut off level of 1.4 (ng/mL) in... | Download Scientific Diagram](https://www.researchgate.net/publication/49772865/figure/tbl4/AS:202581684035593@1425310645400/Comparative-study-stratified-by-the-PSA-cut-off-level-of-14-ng-mL-in-patients-with-BPH.png)
Comparative study stratified by the PSA cut off level of 1.4 (ng/mL) in... | Download Scientific Diagram
![ESMO 2022: Association between prostate-specific antigen decline and clinical outcomes in patients with metastatic castration-resistant prostate cancer in the VISION trial ESMO 2022: Association between prostate-specific antigen decline and clinical outcomes in patients with metastatic castration-resistant prostate cancer in the VISION trial](https://larvolclin.s3.us-west-2.amazonaws.com/resize_166306090938969400863204badaece6.png)
ESMO 2022: Association between prostate-specific antigen decline and clinical outcomes in patients with metastatic castration-resistant prostate cancer in the VISION trial
![Effect of adsorption pressure on PSA performance. (a) CO purity, (b) CO... | Download Scientific Diagram Effect of adsorption pressure on PSA performance. (a) CO purity, (b) CO... | Download Scientific Diagram](https://www.researchgate.net/publication/353942408/figure/fig6/AS:1082760382951448@1635161600333/Effect-of-adsorption-pressure-on-PSA-performance-a-CO-purity-b-CO-recovery-and-c.png)